Cancer and Metastasis Reviews

eISSN: 1573-7233pISSN: 0167-7659

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
13
Eigenfactor
0.005 - 0.01
H-Index
158
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.94
4
Time to Publish
time-to-publish View Chart
4  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
  • Publisher
    SPRINGER
  • Language
    English
  • Frequency
    Quarterly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 26%
4-6 53%
7-9 19%
>9 2%

Topics Covered

Mucin
Cancer
Tumor progression
Platelet
Cytoskeleton
Proteasome
Immunotherapy
Lung cancer
CDK inhibitor
Medulloblastoma
Systemic therapy
Chemotherapy
Cyclooxygenase
Systematic review
Smooth muscle
Pancreatic cancer
Carcinogenesis
Bone marrow
Extracellular matrix
Tumor microenvironment

Recently Published Papers

Year-wise Publication

FAQs

Since when has Cancer and Metastasis Reviews been publishing? Faqs

The Cancer and Metastasis Reviews has been publishing since 1982 till date.

How frequently is the Cancer and Metastasis Reviews published? Faqs

Cancer and Metastasis Reviews is published Quarterly.

What is the H-index. SNIP score, Citescore and SJR of Cancer and Metastasis Reviews? Faqs

Cancer and Metastasis Reviews has a H-index score of 158, Citescore of 13, SNIP score of 1.94, & SJR of Q1

Who is the publisher of Cancer and Metastasis Reviews? Faqs

The publisher of Cancer and Metastasis Reviews is SPRINGER.

How can I view the journal metrics of Cancer and Metastasis Reviews on editage? Faqs

For the Cancer and Metastasis Reviews metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Cancer and Metastasis Reviews? Faqs

The eISSN number is 1573-7233 and pISSN number is 0167-7659 for Cancer and Metastasis Reviews.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Mucin, Cancer, Tumor progression, Platelet, Cytoskeleton, Proteasome, Immunotherapy, Lung cancer, CDK inhibitor, Medulloblastoma, Systemic therapy, Chemotherapy, Cyclooxygenase, Systematic review, Smooth muscle, Pancreatic cancer, Carcinogenesis, Bone marrow, Extracellular matrix, Tumor microenvironment.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.